drugset / Trial / NCT00025207
Gefitinib in Treating Patients With Malignant Mesothelioma
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of gefitinib in treating patients who have malignant mesothelioma. Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of malignant mesothelioma
Timeline
- Start
- 2001-09
- Primary completion
- 2006-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | — | Oral |